drugset / Trial / NCT04620161
A Proof of Concept Study of Pradigastat in Patients With Functional Constipation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of pradigastat 20 and 40 mg as compared to placebo in patients with Functional Constipation.
Timeline
- Start
- 2020-09-22
- Primary completion
- 2022-04-30
- Completion
- 2022-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pradigastat | Small molecule | 20 mg | Oral |
| Subject | Pradigastat | Small molecule | 40 mg | Oral |